Metabolically engineered probiotic nanovaccine shows sequential immunomodulation for chronic MRSA bone infection treatment
This article presents research on developing a metabolically engineered nanovaccine using Lactococcus lactis outer membrane vesicles (Lac-OMVs) for treating chronic, drug-resistant bone infections caused by MRSA. The researchers screened Lac-OMVs and developed NAD+-Lac-OMV nanovaccines that sequentially modulate the immune system — first activating dendritic cells to fight infection, then reprogramming inflammatory macrophages to promote anti-inflammation and bone repair. The approach addresses the challenge of an immunosuppressive niche that enables persistent infection and impaired bone healing in chronic osteomyelitis.
Key quotes
Chronic, drug-resistant bone infection caused by methicillin-resistant Staphylococcus aureus (MRSA) features an immunosuppressive niche enabling persistent infection and impaired bone healing.
A specific treatment requires initial antibacterial immune activation against infection, followed by reshaping an anti-inflammatory microenvironment for later bone repair.
Lei et al. screen Lactococcus lactis OMVs (Lac-OMVs) and develop a metabolically engineered NAD+-Lac-OMV nanovaccine with potent tissue-repair therapeutic effects.
NAD+-Lac-OMVs sequentially activate dendritic cells by membrane components and reprogram inflammatory macrophages for anti-inflammation and bone repair by interior nicotinamide metabolites.
From the article
You might also wanna read
Diet–microbiome synergy underlies obesity-associated immunotherapy efficacy
Diet–microbiome synergy underlies obesity-associated immunotherapy efficacy

Extracellular Vesicles as Anti-Aging Therapeutics: Mechanisms, Bioengineering, and Clinical Perspectives
This comprehensive review article systematically examines the anti-aging potential of extracellular vesicles (EVs), focusing on their multif

Antibiotic stress drives protein transfer between bacteria via membrane vesicles, aiding persister cell survival
This article reports on a scientific discovery showing that antibiotic stress triggers protein exchange between neighboring bacteria through

La creatina no solo desarrolla músculo: un estudio revela su potencial para fortalecer la inmunoterapia contra el cáncer

Study identifies MD-1 as endogenous agonist for orphan receptor GPRC5B, linking macrophages to adipocyte signaling
This article describes research identifying MD-1 as an endogenous agonist for the orphan G protein-coupled receptor GPRC5B. Using a virion-b
UCLA study: Creatine supplementation boosts dendritic cells, slows tumor growth in mice
A UCLA study published in iScience found that creatine, commonly used as a sports supplement, supercharges dendritic cells — specialized imm

Comments
Sign in to join the conversation.
No comments yet. Be the first.